Premium
Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy
Author(s) -
SatoSano Marcelo,
Teixeira Solange Pistori,
Vargas Juliano Cordova,
Baiocchi Otávio Cesar Carvalho Guimarães,
Enokihara Milvia Maria Simões e Silva,
Gomes Elimar Elias,
Batista Mariana Dias
Publication year - 2019
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.14916
Subject(s) - lenalidomide , medicine , malignancy , chronic lymphocytic leukemia , eosinophilic , mantle cell lymphoma , hematologic malignancy , lymphoma , dermatology , eosinophilia , pathology , hematological malignancy , leukemia , multiple myeloma
Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B‐cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy.